A review of potential pharmacogenetic effects on catecholamine responses

References

• Banaś A, Płońska E, Larysz B, et al. (2012). Influence of 825 C>T polymorphism of G protein β3 subunit gene (GNB3) on hemodynamic response during dobutamine stress echocardiography. Pharmacol Rep 64:123–128
   PubMed Web of Science ®Google Scholar
• Barbeau P, Litaker MS, Jackson RW, Treiber FA. (2003). A tyrosine hydroxylase microsatellite and hemodynamic response to stress in a multi-ethnic sample of youth. Ethn Dis 13:186–192
   PubMed Web of Science ®Google Scholar
• Brodde OE. (2008). Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases. Fundam Clin Pharmacol 22:107–125
   PubMed Web of Science ®Google Scholar
• Chen Y, Wen G, Rao F, et al. (2010). Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure. J Hypertens 28:76–86
   PubMed Web of Science ®Google Scholar
• Cheon KA, Ryu YH, Kim JW, Cho DY. (2005). The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: Relating to treatment response to methylphenidate. Eur Neuropsychopharmacol 15:95–101
   PubMed Web of Science ®Google Scholar
• Chitbangonsyn SW, Mahboubi P, Walker D, et al. (2003). Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: A somatic cell radiation hybrid library approach. J Hum Hypertens 17:319–324
   PubMed Web of Science ®Google Scholar
• Craig SP, Buckle VJ, Lamouroux A, et al. (1988). Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 48:48–50
   PubMedGoogle Scholar
• Dempsey EM, Barrington KJ, Marlow N, et al. HIP Consortium. (2014). Management of hypotension in preterm infants (The HIP Trial): A randomised controlled trial of hypotension management in extremely low gestational age newborns. Neonatology 105:275–281
   PubMed Web of Science ®Google Scholar
• Farzaneh-Far R, Desir GV, Na B, et al. (2010). A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: Data from the heart and soul study. PLoS ONE 5:e13496
   PubMed Web of Science ®Google Scholar
• Flatmark T. (2000). Catecholamine biosynthesis and physiological regulation in neuroendocrine cells. Acta Physiol Scand 168:1–17
   PubMedGoogle Scholar
• Graham LA, Padmanabhan S, Fraser NJ, et al. (2014). Validation of uromodulin as a candidate gene for human essential hypertension. Hypertension 63:551–558
   PubMed Web of Science ®Google Scholar
• Hamm HE. (1998). The many faces of G protein signaling. J Biol Chem 273:669–672
   PubMed Web of Science ®Google Scholar
• Heinz A, Goldman D, Jones DW, et al. (2000). Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133–139
   PubMed Web of Science ®Google Scholar
• Huh YH, Jeon SH, Yoo SH. (2003). Chromogranin B-induced secretory granule biogenesis: Comparison with the similar role of chromogranin A. J Biol Chem 278:40581–40589
   PubMed Web of Science ®Google Scholar
• Jacobsen LK, Staley JK, Zoghbi SS, et al. (2000). Prediction of dopamine transporter binding availability by genotype: A preliminary report. Am J Psychiatry 157:1700–1703
   PubMed Web of Science ®Google Scholar
• Jia H, Hingorani AD, Sharma P, et al. (1999). Association of the G(s)alpha gene with essential hypertension and response to beta-blockade. Hypertension 34:8–14
   PubMed Web of Science ®Google Scholar
• Kiani JG, Saeed M, Parvez SH, Frossard PM. (2005). Association of G-protein beta-3 subunit gene (GNB3) T825 allele with type II diabetes. Neuro Endocrinol Lett 26:87–88
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Nagatsu T. (2005). Molecular genetics of tyrosine 3-monooxygenase and inherited diseases. Biochem Biophys Res Commun 338:267–270
   PubMed Web of Science ®Google Scholar
• Lafuente A, Bernardo M, Mas S, et al. (2007). Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics. Schizophr Res 90:115–122
   PubMed Web of Science ®Google Scholar
• Leone M, Martin C, Michel F. (2008). Sympathomimétiques: Pharmacologie et indications thérapeutiques en réanimation. Anesthésie-Réanimation
   Google Scholar
• Liang S, Liu X, Fan P, et al. (2012). Association between Val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population. Arch Med Res 43:154–158
   PubMed Web of Science ®Google Scholar
• Lynch DR, Mozley PD, Sokol S, et al. (2003). Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Mov Disord 18:804–812
   PubMed Web of Science ®Google Scholar
• Mao YM, Liu ZQ, Chen BL, et al. (2009). Effect of 393T>C polymorphism of GNAS1 gene on dobutamine response in Chinese healthy subjects. J Clin Pharmacol 49:929–936
   PubMed Web of Science ®Google Scholar
• Martinez D, Gelernter J, Abi-Dargham A, et al. (2001). The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24:553–560
   PubMed Web of Science ®Google Scholar
• Mason DA, Moore JD, Green SA, Liggett SB. (1999). A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274:12670–12674
   PubMed Web of Science ®Google Scholar
• McLean RC, Baird SW, Becker LC, et al. (2012). Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors. Am J Cardiol 110:1001–1007
   PubMed Web of Science ®Google Scholar
• Morón JA, Brockington A, Wise RA, et al. (2002). Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines. J Neurosci 22:389–395
   PubMed Web of Science ®Google Scholar
• Nagatsu T. (1995). Tyrosine hydroxylase: Human isoforms, structure and regulation in physiology and pathology. Essays Biochem 30:15–35
   PubMed Web of Science ®Google Scholar
• Padmanabhan S, Melander O, Johnson T, et al. (2010). Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 6:e1001177
   PubMed Web of Science ®Google Scholar
• Rao F, Zhang L, Wessel J, et al. (2007). Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: Discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 116:993–1006
   PubMed Web of Science ®Google Scholar
• Rao F, Zhang K, Zhang L, et al. (2010). Human tyrosine hydroxylase natural allelic variation: Influence on autonomic function and hypertension. Cell Mol Neurobiol 30:1391–1394
   PubMed Web of Science ®Google Scholar
• Rigo V, Beauduin P, Rigo J. (2007). Hypotension in the very preterm infant. Rev Med Liege 62:86–93
   PubMedGoogle Scholar
• Robertson D, Haile V, Perry SE, et al. (1991). Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation. Hypertension 18:1–8
   PubMed Web of Science ®Google Scholar
• Rosskopf D, Schürks M, Rimmbach C, Schäfers R. (2007). Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol 374:429–469
   PubMed Web of Science ®Google Scholar
• Roten LT, Fenstad MH, Forsmo S, et al. (2011). A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2). Mol Hum Reprod 17:439–446
   PubMed Web of Science ®Google Scholar
• Sharma P, Hingorani A, Jia H, et al. (1998). Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension. Hypertension 32:676–682
   PubMed Web of Science ®Google Scholar
• Siffert W, Rosskopf D, Siffert G, et al. (1998). Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 18:45–48
   PubMed Web of Science ®Google Scholar
• Subhedar NV. (2003). Treatment of hypotension in newborns. Semin Neonatol 8:413–423
   PubMedGoogle Scholar
• Van de Giessen EM, de Win MML, Tanck MWT, et al. (2009). Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 50:45–52
   PubMed Web of Science ®Google Scholar
• Van Dyck CH, Malison RT, Jacobsen LK, et al. (2005). Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46:745–751
   PubMed Web of Science ®Google Scholar
• Xu J, Li G, Wang P, et al. (2005). Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 115:1275–1280
   PubMed Web of Science ®Google Scholar
• Yan M, Webster LT, Blumer JL. (2002). 3-O-methyldobutamine, a major metabolite of dobutamine in humans. Drug Metab Dispos 30:519–524
   PubMed Web of Science ®Google Scholar
• Zhang K, Rao F, Rana BK, et al. (2009). Autonomic function in hypertension; Role of genetic variation at the catecholamine storage vesicle protein chromogranin B. Circ Cardiovasc Genet 2:46–56
   PubMed Web of Science ®Google Scholar
• Zhao Q, Fan Z, He J, et al. (2007). Renalase gene is a novel susceptibility gene for essential hypertension: A two-stage association study in northern Han Chinese population. J Mol Med 85:877–885
   PubMed Web of Science ®Google Scholar